Professor Andrew Scott AM
MBBS (Hons), MD, FRACP, FAHMS, FAANMS, FAICD, DDU
Research Translation & Commercialisation Lead
Head, Tumour Targeting Program and Laboratory, Olivia Newton-John Cancer Research Institute, Director, Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Professor, Department of Medicine, University of Melbourne.
View alliance profile
Professor Scott’s 20-year career as a cancer clinician/scientist features a host of leading research roles, including as Director of the Ludwig Institute for Cancer Research (Austin Branch) and President of the World Federation of Nuclear Medicine and Biology, as well as Professorial appointments at the University of Melbourne, La Trobe University and Monash University.
An NHMRC fellow and Order of Australia recipient, he is currently the Director, Department of Molecular Imaging and Therapy at Austin Health, Head of the Tumour Targeting Program at the Olivia Newton-John Cancer Research Institute (ONJCRI), and a member of the VCCC Alliance Centre for Cancer Immunotherapy Advisory Group.
As Research Translation & Commercialisation Lead, Professor Scott will bring a commercial lens to research activities conducted within the VCCC Alliance, acting as a key cog in the translation of research discoveries into commercial assets, an area which has historically been under-resourced in Victoria.
He will also support the acceleration of novel therapies to the clinic, and clinical trial innovation within the VCCC Alliance to ensure optimal program implementation leading to downstream improvement in patient outcomes.
Professor Scott has published over 330 peer-reviewed papers and 22 book chapters, principally in the areas of oncology and molecular imaging. His invited reviews in leading journals include Nature Reviews Cancer, Nature Reviews Clinical Oncology and Cancer Research.